Chairman and CEO
Former venture capitalist: Founder and CEO of Quantica SGR, Founder and Investment Manager of Axòn Capital and Venture Consultant of Sofinnova Partners; Investor and Board Director at EOS – Ethical Oncology Science.
McKinsey & Company emeritus director and former board member at Luxottica (NYSE:LUX) and COFIDE (IT:COF). Now, Board Director at Teva (NYSE: TEVA) and Admiral (LSE: ADM). Chairman of the INSEAD’s advisory group in Italy.
Stefano Nanni Costa
Partner at Legal Firm Lombardi Molinari & Co., Board Member at Zambon Education Foundation, Auditor at Z-Cube (Zambon Pharma Group)
35 years at global top positions in big pharmaceuticals at all levels; managed staff up to 7,000 employees with turnover over 7B€; former Head of Pharma EU at Novartis, previously Head of Oncology at Novartis EU (drugs: Cosentyx, Entresto, Lucentis, Gilenya, Xolair, Ultibro, Seebri, Galvus, Exforge and others)
Genextra’s chief financial officer, previously director of finance and strategic planning for the Fastweb Group. Board director at Intercept Pharmaceuticals (NASDAQ: ICPT), EryDel and Tethis.